New vaccine candidate for cervical cancer.(Pulse: The heartbeat of the marketplace)(Brief article)

From: CME: Your SA Journal of CPD | Date: May 1, 2007 | Copyright information

GlaxoSmithKline (GSK) has submitted a Biologics License Application (BLA) for its cervical cancer candidate vaccine (Cervarix), to the US Food and Drug Administration (FDA).

Cervarix is a human papillomavirus vaccine (AS04 adjuvant-adsorbed) that, if licensed, will be indicated for the prevention of cervical cancer and precancerous lesions associated with the most common cancer-causing human papillomavirus types. For this candidate vaccine, GSK selected a novel proprieta...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

FINALLY, A VACCINE FOR CERVICAL CANCER
The Manila Times ; IF it passes the scrutiny of local and international regulatory bodies, one of the first few candidate vaccines for cervical cancer will be made available soon in the Philippines, where the illness affects 22 out of 100,000 Filipinas every year. The candidate vaccine, released by the pharmaceutical
Cervarix for protection against cervical cancer.(Pulse: The heartbeat of the marketplace)
CME: Your SA Journal of CPD ; GlaxoSmithKline's (GSK's) cervical cancer candidate vaccine, Cervarix, demonstrated 100% efficacy in preventing precancerous lesions due to cancer-causing human papillomavirus types 16 and 18 for up to 5.5 years. This efficacy was demonstrated in an extended follow-up trial conducted by GSK, and is
January is cervical cancer awareness month.
Vermont Nurse Connection ; Approximately 31 women in Vermont are diagnosed with cervical cancer each year. One of those women is Allison Hicks, a doula who was diagnosed at age 29 with advanced cervical cancer. Her message: Cervical cancer is preventable. Her foundation, the Hicks Foundation, sponsors, among other
RAISING AWARENESS OF CERVICAL CANCER:SHERROD BROWN
Congressional Testimony ; 00-00-0000 Statement of U.S. Congressman Sherrod Brown (D-OH) Ranking Member, Commerce Subcommittee on Health and Environment Women's Health: Raising Awareness of Cervical Cancer Tuesday, March 16, 1999 Mr. Chairman, thank you for arranging today's hearing. I'd also like to thank Mr. Mack, Ms.
4 vital facts about cervical cancer: it's one of the most preventable women's cancers. Here's how to stay safe.(handbook: VERY PERSONAL HEALTH)
Redbook ; Cervical cancer recently took the spotlight when the FDA approved a cervical cancer vaccine called Gardasil, which protects against the human papillomavirus (HPV), a sexually transmitted infection that causes the majority of cervical cancer cases. The vaccine is recommended for girls and women ages